Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
CA 2436741 A1 · Owner: Akella, Venkateswarlu · Inventors: Purma, Papi Reddy; Ranjan, Chakrabarti; Akella, Venkateswarlu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel antiobesity and hypocholesterolemic compounds, their derivatives, their analogs their tautomeric forms, their , stereoisomers their polymorphs, their pharmaceutically acceptable salts their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly the present invention relates , to novel b-aryl-a-oxysubstituted alkylcarboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms their , stereoisomers, their polymorphs their pharmaceutically acceptable salts their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 5, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.